Adcirca
The United States Food and Drug Administration (FDA) has approved Adcirca (tadalafil) tablets for oral administration, with a recommended dose of 40 mg, as the first once-daily phosphodiesterase type 5 (PDE5) inhibitor for the treatment of pulmonary arterial hypertension (PAH). Adcirca is indicated...
Consumer Information (Drugs.com) · More like this · Add to my drug list

Adcirca
Adcirca is used for: Treating high blood pressure in the lungs.
Consumer Information (MedFacts) · More like this · Add to my drug list

Adcirca

Advanced Consumer Information (Micromedex) · More like this · Add to my drug list

Adcirca
ADCIRCA (tadalafil), an oral treatment for pulmonary arterial hypertension, is a selective inhibitor of cyclic guanosine monophosphate (cGMP)–specific phosphodiesterase type 5 (PDE5). Tadalafil has the empirical formula C22H19N3O4 representing a molecular weight of 389.41. The structural...
Professional Monographs (FDA) · More like this · Add to my drug list

Tadalafil
Tadalafil Pronunciation: (ta-DAL-a-fil) Class: Phosphodiesterase type 5 inhibitor Trade Names: Adcirca - Tablets 20 mg Trade Names: Cialis - Tablets 2.5 mg - Tablets 5 mg - Tablets 10 mg - Tablets 20 mg Pharmacology Adcirca Inhibition of phosphodiesterase...
A-Z Drug Facts (Facts & Comparisons) · More like this · Add to my drug list

See also: Pulmonary Arterial Hypertension

Having trouble finding what you want?

• Try browsing our A-Z List of Drug Names or our Medical Encyclopedia.
• Try posting your query on the Drugs.com Community Discussion Boards
• Drug Interactions Checker provides detailed information on drug-drug and drug-food interactions.
• Pill Identifier will help you identify an unknown pill by imprint code or shape/color.
• Image Search is helpful if you want to know what a certain pill looks like.
• News, FDA Approvals or In The Pipeline may help if the drug you are looking for is a new drug.